A Practical Guide to Human Biospecimens: Types, Formats, and Research Applications

GUIDE

Guides

Human biospecimens are foundational to modern drug discovery. From early-stage research through translational and clinical development, they provide the most direct way to study human biology, disease mechanisms, and therapeutic response.

But not all biospecimens are created equal.

Understanding the type, format, and intended application of a sample is critical to designing effective studies—and avoiding costly downstream issues.

What Is a Biospecimen?

A biospecimen includes any biological material used for research, such as:

  • Tissue (tumor or normal)
  • Blood and other biofluids
  • Cells (e.g., PBMCs, tumor cells)
  • DNA, RNA, and proteins

These materials may be used immediately in experiments or stored in biorepositories for future research.

Why Specimen Selection Matters

Choosing the wrong specimen format can compromise results—no matter how strong the study design.

The right selection impacts:

  • Data quality and reproducibility
  • Assay compatibility
  • Biomarker discovery success
  • Translational relevance

In short: specimen strategy is experimental strategy.

Tissue Specimens: Formats and Use Cases

FFPE (Formalin-Fixed, Paraffin-Embedded)

Best for: Histology, IHC, FISH, and many clinical assays

  • Standard format for pathology and diagnosis
  • Suitable for mutation analysis and biomarker studies
  • Long-term storage, but nucleic acid quality can degrade over time

Key considerations:

  • Block age (ideally <3–5 years for molecular work)
  • Tumor content (typically >30–50%)
  • Necrosis levels

Snap-Frozen (Flash-Frozen)

Best for: DNA, RNA, and protein analysis

  • Preserves molecular integrity better than FFPE
  • Enables high-quality genomic and proteomic studies

Trade-off:

  • Limited visibility into tumor composition unless paired with mirrored FFPE

Fresh Tissue

Best for: Functional assays and microenvironment studies

  • Preserves tumor architecture and immune context
  • Used in immuno-oncology and biomarker discovery
  • Supports PDX model development

Constraint: Short viability window and complex logistics

Viably Preserved Tissue

Best for: Extended functional studies

  • Maintains cell viability with specialized processing
  • Bridges the gap between fresh tissue and cryopreserved formats

Dissociated Tumor Cells (DTCs)

Best for: Cell-based assays and scalable studies

  • Generated via enzymatic/mechanical dissociation
  • Suitable for FACS, single-cell genomics, and screening

Trade-off: Loss of native tumor architecture

Biofluids: Flexible and Scalable Options

Whole Blood (Fresh)

Applications: PBMC isolation, immunoprofiling, cell culture

Frozen Whole Blood

Applications: DNA and RNA extraction

Plasma

Applications:

  • ctDNA / ctRNA
  • miRNA and exosome analysis
  • Liquid biopsy workflows

Serum

Applications:

  • Tumor marker analysis (e.g., CEA, CA125)
  • Proteomics and biomarker discovery
  • Autoimmune disease research

Bone Marrow Aspirates

Applications: Hematologic studies and molecular analysis

Cell-Based Specimens

PBMCs (Peripheral Blood Mononuclear Cells)

  • Widely used in immunology and cell-based assays
  • Support genomics, proteomics, and functional studies

BMMCs (Bone Marrow Mononuclear Cells)

  • Critical for hematology and oncology research

Dissociated Tumor Cells

  • Enable single-cell analysis and immune profiling

Nucleic Acids and Derived Materials

DNA & RNA

Applications:

  • Next-generation sequencing (NGS)
  • RT-PCR
  • Transcriptomics and gene expression studies

Protein Lysates

  • Western blotting
  • Proteomics
  • Immunoprecipitation

Downstream Applications: Where Biospecimens Deliver Value

Human biospecimens support a wide range of research applications:

  • Disease mechanism studies
  • Drug safety and efficacy testing
  • Biomarker discovery and validation
  • Diagnostic development
  • Personalized medicine approaches

They also provide a more clinically relevant model than synthetic systems or animal models.

Choosing the Right Biospecimen Strategy

Selecting a biospecimen provider—and the right format—requires careful evaluation.

Key considerations:

  • Quality and consistency of samples
  • Ethical sourcing and regulatory compliance
  • Processing and handling protocols
  • Availability of matched samples and metadata
  • Ability to support custom collection protocols

A strong partner should not just supply samples—but help align specimen strategy with study goals.

How ABS Bio Supports Researchers

ABS Bio works with biopharma and research teams to deliver fit-for-purpose biospecimens aligned with study design.

Our capabilities include:

  • Broad access to tissue, biofluid, and cell-based specimens
  • Standardized, quality-controlled procurement and processing
  • Support for custom protocols and complex study requirements
  • Reliable logistics and consistent sample delivery

By combining quality, flexibility, and operational discipline, ABS Bio helps researchers reduce variability and improve study outcomes.

Conclusion

Human biospecimens are among the most powerful tools in biomedical research—but only when used correctly.

Understanding specimen types, formats, and applications is essential to designing effective studies and generating meaningful data.

With the right strategy—and the right partner—biospecimens can accelerate discovery, improve translational success, and ultimately bring better therapies to patients.

VLADISLAV GOLUBKOV, PH.D.

Research & Business Development Director, ABS Bio

30+ years in life sciences

Biotechnology expert

45+ peer-reviewed publications

Vladislav Golubkov, Ph.D., is Research & Business Development Director at ABS Bio. He is a biotechnology expert with over 30 years of industry and academic experience in biospecimen solutions, biobanking, cell and molecular biology, and translational research. Dr. Golubkov specializes in the commercialization of custom biospecimen and research services, partnering with pharmaceutical and biotechnology companies to deliver high-quality, fit-for-purpose solutions for drug discovery and clinical development across diverse therapeutic areas. He has extensive experience aligning scientific operations with client and market needs to drive revenue growth and long-term partnerships.

Prior to his current role, Dr. Golubkov held scientific and leadership positions at the University of Southern California (USC), Sanford Burnham Prebys Medical Discovery Institute, and Cureline Inc.

He is a published author of over 45 peer-reviewed articles and a former NIH-funded principal investigator.

2026-08-06T16:08:24-04:00Guides|

Flow Cytometry

GUIDE

Guides

Flow cytometry is a brilliant tool for exploring the individual characteristics of cell lines and tissues.

What is flow cytometry?

  • Flow cytometry is a method to perform rapid, multi-parameter analysis and characterization of individual cells or particles.
  • Measurements are taken as single cells or particles pass either a single or multiple lasers.
  • These cells or particles are evaluated for visible light scatter and fluorescence.
    • Light scatter can be used to determine size, granularity, and even distinguish individual populations in certain cell systems.
    • Fluorescence can be used to evaluate viability, surface and intracellular protein expression, and distinguish individual populations based on phenotype.

How does flow cytometry work?

Flow cytometry is an immunostaining method that utilizes the protein/antibody interaction. Antibodies (primary or secondary) are conjugated to a specific fluorochrome (i.e., FITC, APC, PE, etc.; Fig 1). These fluorochromes are excited by one of the cytometer lasers at a specific wavelength and will emit at another wavelength which will be read by the cytometer.

Figure 1. Diagram depicting binding of fluorochrome-conjugated antibodies to their respective surface receptors and how these populations can be distinguished by flow cytometry.

Why choose flow cytometry over other protein analytical systems?

Table 1. List of advantages to using flow cytometry and how western blot and immunohistochemistry (IHC) techniques measure up.

*This comparison is based on the benefits of flow cytometry. Western blot and IHC are both useful techniques in other applications.

What are some practical applications of flow cytometry?

  • Verification of cell lines using surface immunophenotyping
  • Confirmation of proper differentiation following induction experiments
  • Quantitative assessment of GFP or other overexpression/knockdown target transfections
  • Characterization of dissociated tumor cells
  • Measurement of a target’s fluorescence intensity
  • Quantitative evaluation of surface receptor density
  • …and many more!

Cell Sorting

Flow cytometry is a wonderful method for exploring cell lines and tissues, but it is not limited to providing just analytical data.

What is cell sorting?

  • Cell sorting is a method that utilizes the same principles of flow cytometry but provides pure populations of live cells “in hand” to work with.
  • These cells are distinguished and sorted by scatter and/or fluorescence.

How are cells sorted?

  • Cells are sorted in a sterile manner and can be used for downstream applications that require aseptic technique such as culturing or CFU assays.
  • Cells can be sorted two ways:
    • Bulk sorting
    • Single-cell sorting

What are some practical applications of cell sorting?

  • Bulk sorting:
    • Purify a population of interest from dissociated tumor cells, including rare populations
    • Select for GFP+ transfected cells to create a pooled cell line
    • Sort to exclude unmanipulated cells from an engineered cell pool
  • Single-cell sorting:
    • Perform easy limiting-dilution assays
    • Dispense cells to generate clones of GFP or overexpression/knockdown target transfections
    • Sort a specific population for single-cell technologies, such as RNA- or DNA- sequencing
    • Measure the fluorescence intensity for targets of interest for each individual, sorted cell
  • …and many more!

All of these capabilities along with cell culture services are available to you at ABS Bio. Please contact us to design a study that will meet your experimental needs.

VLADISLAV GOLUBKOV, PH.D.

Research & Business Development Director, ABS Bio

30+ years in life sciences

Biotechnology expert

45+ peer-reviewed publications

Vladislav Golubkov, Ph.D., is Research & Business Development Director at ABS Bio. He is a biotechnology expert with over 30 years of industry and academic experience in biospecimen solutions, biobanking, cell and molecular biology, and translational research. Dr. Golubkov specializes in the commercialization of custom biospecimen and research services, partnering with pharmaceutical and biotechnology companies to deliver high-quality, fit-for-purpose solutions for drug discovery and clinical development across diverse therapeutic areas. He has extensive experience aligning scientific operations with client and market needs to drive revenue growth and long-term partnerships.

Prior to his current role, Dr. Golubkov held scientific and leadership positions at the University of Southern California (USC), Sanford Burnham Prebys Medical Discovery Institute, and Cureline Inc.

He is a published author of over 45 peer-reviewed articles and a former NIH-funded principal investigator.

2026-08-06T11:55:09-04:00Guides|

What is Mycoplasma?

GUIDE

Guides

Mycoplasma are small free-living organisms, considered to be among the simplest of bacteria. Due do their lack of a cell wall, they can be resistant to many common antibiotics. Mycoplasma contamination can come from infected cells from another lab, contaminated cell medium reagents, and/or laboratory personnel infected with strains like M. orale or M. fermentans.

These organisms may spread, making experiments with contaminated cells potentially useless by changing how the cells react, which can lead to an extensive waste of time and resources. Regular testing of cell lines for mycoplasma contamination is recommended to protect your cells and research when receiving lines from another laboratory, after 10 passages, after preparation for a cell bank, and/or when in doubt.

Methods for Preventing Mycoplasma Contamination

  • Good aseptic techniques
  • Cleaning surfaces regularly
  • Proper PPE (lab coat, protective eyewear, long pants, and closed toe shoes)
  • Routine testing for potential contamination
  • Keeping media and ideally incubators separate for each cell line

Methods for Testing for Mycoplasma Contamination

  • PCR-based testing
  • Staining
  • Agar and broth culture

The PCR method (Polymerase Chain Reaction) is a lab technique used to make multiple copies of DNA, which is highly sensitive at identifying many species of bacteria and provides rapid results.

PCR How-To

ABS Bio’s sensitive and specific PCR-based method tests your cells or media samples for multiple strains of mycoplasma. We use an Agilent 2100 Bioanalyzer for the analysis of amplified PCR fragments from any mycoplasma presents, resulting in precise, fast, and cost-effective mycoplasma testing.

First, prepare the samples using standard laboratory procedures. If necessary, you may need to also prepare a diluted positive/negative control.

Dependent on the machine or kit you are using, each will come with its own set of instructions. Some companies choose to forego this tedious process and outsource it to another lab, such as ABS, which takes care of all of this and provides the information by the assigned timeline given.

What Happens if the Sample Tested Positive for Mycoplasma?

  • Destroy contaminated cells and start over
  • Treat with trypsin, S-bromouracil, antisera, etc. (may help)
  • Antibiotics can help, but you’ll need to know which myco strains you are fighting
    • Using a mix of various antibiotics may offer best results

Cleaning up a cell line contaminated with mycoplasma is difficult and can be a waste of resources and not generally recommended. However, if the cell line is unique or hard to acquire, it would be best to treat it, as you may not be able to acquire that particular group or cells/cell line in time for your project.

Plasmocin®, a broad-spectrum mycoplasma and related cell wall-less bacteria removal reagent, is effective against common Mycoplasma strains, both extracellular and intracellular. Different procedures will need to be followed for adherent and suspension cultures.

If you choose to clean the mycoplasma from a cell line, removing it away from other cell lines (ideally in an environment such as a dedicated Quarantine laboratory space) will prevent the infection of other cell cultures that might cause a potentially catastrophic chain reaction.

After a Mycoplasma test comes back negative with normal media, the cells are deemed Mycoplasma negative and the job for Mycoplasma Cleanup can be continued if there are vials to freeze. Testing should be repeated over a several week period because some

Mycoplasma strains grow slowly and may not be immediately detectable.      In all cases, mycoplasma test results should be recorded for recordkeeping purposes.

How ABS Bio Can Help

Generally, this procedure is lengthy and can waste precious research time for any scientist or laboratory. Outsourcing this project to ABS could save you the time, money, and resources. Our laboratory personnel make it a priority to get your cells where they need to be, so you can focus on more important tasks.

Request a consultation at ABS to talk to one of our highly skilled and knowledgeable sales team who will speak with you about your projects and needs. Together, we will come up with a personalized plan of action to help you reach your goals with us.

VLADISLAV GOLUBKOV, PH.D.

Research & Business Development Director, ABS Bio

30+ years in life sciences

Biotechnology expert

45+ peer-reviewed publications

Vladislav Golubkov, Ph.D., is Research & Business Development Director at ABS Bio. He is a biotechnology expert with over 30 years of industry and academic experience in biospecimen solutions, biobanking, cell and molecular biology, and translational research. Dr. Golubkov specializes in the commercialization of custom biospecimen and research services, partnering with pharmaceutical and biotechnology companies to deliver high-quality, fit-for-purpose solutions for drug discovery and clinical development across diverse therapeutic areas. He has extensive experience aligning scientific operations with client and market needs to drive revenue growth and long-term partnerships.

Prior to his current role, Dr. Golubkov held scientific and leadership positions at the University of Southern California (USC), Sanford Burnham Prebys Medical Discovery Institute, and Cureline Inc.

He is a published author of over 45 peer-reviewed articles and a former NIH-funded principal investigator.

2026-08-06T11:55:26-04:00Guides|

Guide for Selecting Human Biospecimen Providers

GUIDE

Guides

Regulatory Issues

First and foremost, the biospecimen provider must comply with all applicable laws and regulations. These include:

  • Informed Consent:

    • Do their Informed Consent Forms permit the intended use?
    • Do they permit commercial uses?
    • Do they make it clear that the donor will not benefit financially from any discoveries?
    • Do they permit genetic analyses?
  • Material Transfer Agreements:

    • Are the Material Transfer Agreements between acquisition sites and the provider and your organization and the provider consistent with the above?
    • Do they make clear that there are no intellectual property or ownership restrictions on the use of the biospecimens?
  • Sample country of origin:

    • Does the country of origin permit export of human biospecimens?
    • Are the company of origin’s regulatory standards compatible with your intended use?
  • De-identified Donor Data:

    • Is all donor data de-identified in compliance with Healthcare Insurance Portability and Accountability Act (HIPAA) regulations?
  • Certifications and Regulatory:

    • Do they possess any external certifications of their compliance with quality or regulatory standards?
    • Have they undergone any external audits? For example, ABS is ISO9001:2015 certified.
    • Will they permit you to audit their facility?

Collection Processes and SOPs

  • Collection SOP’s:

    • Do they have rigorous sample collection procedures specifying ischemia times, appropriate postmortem intervals, sample preservation and handling, etc.?
  • Chain of Custody:

    • Do they have processes in place for maintaining sample chain of custody?
  • Sample Storage:

    • Do they have monitored and secure sample storage facilities that maintain proper storage sample conditions?

Sample Processing Capabilities

  • Biochemical Sample Processing:

    • Can they extract and purify DNA, RNA, and proteins?
    • Can they isolate specific cell types, such as blood cells?
    • Can they make cell membrane preparations and other cell fractions?
  • Histology and Immunohistochemistry (IHC)

    • Can they prepare and stain slides? Can they prepare tissue microarrays?
    • Can they do IHC methods development and assays?

Sample Data, Analysis, and QC Capabilities

  • Sample Data:

    • Do they provide basic demographics information as well as access to pathology reports and donor medical data?
  • Sample QC:

    • Do they perform any sample QC such as RIN analysis, pathology verification, etc.?
  • Sample Analysis:

    • Can they provide sample analysis: such as RT-qPCR, genotyping, IHC, flow cytometry?
  • Quality Assurance Program:

    • Do they have an active quality assurance plan in place?

Guarantees

  • Sample Data:

    • Do they provide basic demographics information as well as access to pathology reports and donor medical data?
  • Sample QC:

    • Do they perform any sample QC such as RIN analysis, pathology verification, etc.?
  • Sample Analysis:

    • Can they provide sample analysis: such as RT-qPCR, genotyping, IHC, flow cytometry?
  • Quality Assurance Program:

    • Do they have an active quality assurance plan in place?

ABS Bio meets all of these requirements. No other biospecimen provider offers more. We have one of the largest high-quality biospecimen networks in the world to provide you with large sample inventories and prospective collections.

VLADISLAV GOLUBKOV, PH.D.

Research & Business Development Director, ABS Bio

30+ years in life sciences

Biotechnology expert

45+ peer-reviewed publications

Vladislav Golubkov, Ph.D., is Research & Business Development Director at ABS Bio. He is a biotechnology expert with over 30 years of industry and academic experience in biospecimen solutions, biobanking, cell and molecular biology, and translational research. Dr. Golubkov specializes in the commercialization of custom biospecimen and research services, partnering with pharmaceutical and biotechnology companies to deliver high-quality, fit-for-purpose solutions for drug discovery and clinical development across diverse therapeutic areas. He has extensive experience aligning scientific operations with client and market needs to drive revenue growth and long-term partnerships.

Prior to his current role, Dr. Golubkov held scientific and leadership positions at the University of Southern California (USC), Sanford Burnham Prebys Medical Discovery Institute, and Cureline Inc.

He is a published author of over 45 peer-reviewed articles and a former NIH-funded principal investigator.

2026-08-06T11:58:33-04:00Guides|
Go to Top